Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2025.12.15

Pushing Boundaries in Organic Chemistry: IISc Prof. Santanu Mukherjee at Sai Life Sciences

As part of Sai Life Sciences’ ongoing initiative to foster meaningful scientific engagement through interactions with distinguished researchers, Prof. Santanu Mukherjee, Professor in the Department of Organic Chemistry at IISc Bangalore, visited our Integrated R&D campus for a full-day programme of knowledge exchange.

He delivered an insightful masterclass on his group’s work in enantioselective desymmetrization—a powerful strategy for rapidly building molecular complexity and enabling the formation of multiple stereocenters in a single step. The session highlighted organocatalytic desymmetrization reactions developed in his laboratory, including formal C(sp²)–H alkylation and the de novo construction of (hetero)arenes, and their application in the enantioselective synthesis of [3]-ladderanol, [5]-ladderanoic acid, and related analogues. He also discussed recent advances using alkoxy-directed dienamine catalysis for generating unnatural benzo-analogues of ladderanol.

In addition to the masterclass, Prof. Mukherjee joined Dr. Santosh Kulkarni for an engaging Fireside Chat with our scientific community. From the importance of documenting every detail in the lab to the question of what it will take for an Indian chemist to win the Nobel Prize, the conversation offered a candid exploration of the discipline, ambition, and ecosystem needed to push science forward. He reflected on global shifts shaping organic chemistry, the realities of research culture, and why rigor often matters more than brilliance.

Dr. Santanu Mukherjee, one of the country’s leading organic chemists and a global expert in asymmetric catalysis. After research stints in Germany and the US, including Harvard University, he returned to IISc Bangalore to build a laboratory that is now known for breakthrough enantioselective transformations and innovative catalytic approaches. With numerous recognitions and editorial appointments, he continues to shape the direction of contemporary organic chemistry.

Share article

More News

2026.03.27

Inside Sai Life Sciences’ Integrated R&D Campus: Accelerating Drug Development

In a recent feature published in R&D World, Sai Life Sciences’ Integrated R&D Campus in Hyderabad is showcased as a model for accelerating drug discovery and development through true scientific integration.In the article, Dr. B.V.N.B.S. Sarma, Senior Vice President – Discovery, highlights how co-locating multidisciplinary teams—from medicinal chemistry and biology to DMPK, developability, process development, […]
Read more

2026.03.27

Sai Life Sciences hosts Biotech Pitch Day 2026 at Boston Site

Sai Life Sciences successfully hosted its Biotech Pitch Day 2026 at its Boston-area site on March 19, bringing together a dynamic group of emerging biotech innovators, scientific leaders, and industry experts. The event was designed as a platform for early-stage biotech companies to showcase their science, strengthen visibility, and engage with potential collaborators across the […]
Read more

2026.03.25

Kudikunta Lake restoration completed, marking the revival of an urban water body

Kudikunta Lake in Kondapur, Hyderabad, was inaugurated on February 28th following the completion of restoration efforts undertaken by Sai Life Sciences as part of its Corporate Social Responsibility (CSR) initiative in collaboration with the Society for Advancement of Human Endeavour (SAHE). The event marked the culmination of several months of work to restore a previously […]
Read more

2026.03.10

AI-driven retrosynthesis integrated into Discovery Chemistry

Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate an AI-driven retrosynthesis platform into its Discovery Chemistry workflows. The integration enables medicinal chemists to evaluate synthetic routes more rapidly and explore a broader set of feasible pathways during early-stage drug discovery. Retrosynthesis is a […]
Read more

2026.03.10

Structural Biology capabilities launched with X-Ray Crystallography

Sai Life Sciences has introduced integrated structural biology capabilities with the establishment of X-ray protein crystallography workflows to support structure-based drug discovery programs. The platform encompasses end-to-end protein engineering capabilities, including construct design, gene synthesis, and in-house recombinant protein expression and purification. These foundational steps enable generation of high-quality protein material suitable for structural and […]
Read more